On January 22, 2019 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, reported that Dr. Steven M. Fruchtman, President & CEO, will present a company overview at NobleCON15, Noble Capital Markets’ 15th annual small cap and emerging growth investor conference being held January 28th and 29th at the W Hotel in Fort Lauderdale, Florida (Press release, Onconova, JAN 22, 2019, View Source [SID1234532816]). A webcast of the presentation will be available at the link below and on Onconova’s website (View Source) a day after the event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details

Date: Tuesday, January 29th, 2019
Time/Location: 12:00p Studio B
Location: W Fort Lauderdale
Webcast link: View Source